Central Region, Central, Singapore The venture was found in Asia in Singapore. The main department of described VC is located in the Singapore.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Singapore Bio-Innovations, startups are often financed by Sofinnova Investments, Alloy Ventures, MPM Capital. The meaningful sponsors for the fund in investment in the same round are Sofinnova Investments, MPM Capital, GBS Ventures. In the next rounds fund is usually obtained by Sofinnova Investments, Mitsubishi UFJ Capital, MPM Capital.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Diagnostics, Biotechnology. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Aderis Pharmaceuticals, Five Prime Therapeutics, Humanigen
The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Singapore Bio-Innovations performs on 21 percentage points more the average number of lead investments. The average startup value when the investment from Singapore Bio-Innovations is 5-10 millions dollars. The top amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2008.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Humanigen | $20M | 03 Aug 2007 | California, United States | ||
Humanigen | $20M | 16 Mar 2005 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Humanigen | $20M | 03 Aug 2007 | California, United States | ||
Humanigen | $20M | 16 Mar 2005 | California, United States |
